Diabetes and Chronic Kidney Disease

Diabetes Public Health: From Data to Policy

Volumn , Issue , 2011, Pages

  Pavkov, Meda E ^a   Burrows, Nilka R ^a   Knowler, William C ^b   Hanson, Robert L ^b   Nelson, Robert G ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Chronic kidney disease; Diabetes; Disease management; Intervention; Public health program

Indexed keywords

EID: 84920517912     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195317060.003.0007     Document Type: Chapter

References (103)

1. Abrahamson DR, Steenhard BM. (2008). Perinatal nephron programming is not so sweet in maternal diabetes. Journal of the American Society of Nephrology 19, 837-9.
2. Adler AI et al., on behalf of the UKPDS Group (2003). Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International 63, 225-32.
3. American Diabetes Association (2000). Type 2 diabetes in children and adolescents. Diabetes Care 23, 381-9.
4. American Diabetes Association (2007). Clinical practice recommendations. Diabetes Care 30(Suppl. 1), S19-20.
5. Amin R et al. (2008). Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. British Medical Journal 336, 697-701.
6. Bakris GL et al. (2003). Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL Study. Archives of Internal Medicine 163, 1555-65.
7. Barzilay J et al. (1992). Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney International 41, 723-30.
8. Brandle M et al. (2003). The direct medical cost of type 2 diabetes. Diabetes Care 26, 2300-4.
9. Brenner BM et al. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine 345, 861-9.
10. Bryson CL et al. (2006). Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. American Journal of Kidney Disease 48, 720-6.
11. Burrows NR et al. (2005). End-stage renal disease due to diabetes among Southwestern American Indians, 1990-2001. Diabetes Care 28, 1041-4.
12. Centers for Disease Control and Prevention (n.d.a).. Accessed January 23, 2009.
13. Centers for Disease Control and Prevention (n.d.b).. Accessed January 23, 2009.
14. Chase HP et al. (1991). Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. Journal of the American Medical Association 265, 614-7.
15. Chaturvedi N et al. (1995). The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 18, 785-92.
16. Chistiakov DA et al. (2004). Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Research and Clinical Practice 66, 79-86.
17. Chuahirun T et al. (2003). Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. American Journal of Kidney Disease 41, 13-21.
18. Colhoun HM et al. (2001). Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44, S46-53.
19. Collins AJ et al. (2003). Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney International. Supplement 87, S24-31.
20. Cooper ME, Jandeleit-Dahm KA (2005). Lipids and diabetic renal disease. Current Diabetes Reports 5, 445-8.
21. Dabelea D et al. (1998). Increasing prevalence of type II diabetes in American Indian children. Diabetologia 41, 904-10.
22. Davison JM (2001). Renal disorders in pregnancy. Current Opinion in Obstetrics and Gynecology 13, 109-14.
23. Diabetes Control and Complications (DCCT) Research Group (1995). Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney International 47, 1703-20.
24. Foster MC et al. (2007). Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Archives of Internal Medicine 167, 1386-92.
25. Gæde P et al. (2008). Effect of multifactorial intervention on mortality in type 2 diabetes. New England Journal of Medicine 358, 580-9.
26. Gambaro G et al. (2001). Cigarette smoking is a risk factor for nephropathy and its progression in Type 2 diabetes mellitus. Diabetes, Nutrition & Metabolism 14, 337-42.
27. Garg AX et al. (2002). Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney International 61, 2165-75.
28. Gerich JE et al. (2001). Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24, 382-91.
29. Gerstein HC et al. (2001). Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286, 421-6.
30. Hanson RL et al. (2007). Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56, 975-83.
31. Hart PD, Bakris GL (2004). Managing hypertension in the diabetic patient. In: Egan BM, Basile JN, Lackland DT, eds. Hot Topics in Hypertension, pp 249-52. Philadelphia: Hanley & Belfus.
32. Hogg RJ et al. (2003). National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Chronic Kidney Disease in Children and Adolescents: evaluation, classification, and stratification. Pediatrics 111, 1416-21.
33. Ibsen H et al. (2006). Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care 29, 595-600.
34. Imperatore G et al. (2004). Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. American Journal of Epidemiology 160, 531-9.
35. Iyengar SK et al. (2007). Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 56, 1577-85.
36. Jaimes EA et al. (2007). Nicotine: the link between cigarette smoking and the progression of renal injury? American Journal of Physiology. Heart and Circulatory Physiology 292, H76-82.
37. Jones CA et al. (2002). Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. American Journal of Kidney Disease 39, 445-59.
38. Jones DC, Hyslett JP (1996). Outcome of pregnancy in women with moderate to severe renal insufficiency. New England Journal of Medicine 335, 226-32.
39. Kaplan N (1998). J-curve not burned off by HOT study. Hypertension Optimal Treatment. Lancet 351, 1748-9.
40. Kasiske BL et al. (1998). A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Disease 31, 954-61.
41. Keane WF et al. (2003). The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney International 63, 1499-507.
42. Klein R, Klein BE, Moss SE (1993). Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 16, 1325-30.
43. Knowler WC et al. (1990). Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis. Diabetes/Metabolism Reviews 6, 1-27.
44. Knowler WC et al. (2005). The Family Investigation of Nephropathy and Diabetes (FIND):design and methods. Journal of Diabetes Complications 19, 1-9.
45. Krakoff J et al. (2003). Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 26, 76-81.
46. Krolewski AS et al. (1988). Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. New England Journal of Medicine 318, 140-5.
47. Krolewski AS et al. (1995). Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. New England Journal of Medicine 332, 1251-5.
48. Kuo YF et al. (2003). Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care 26, 3054-60.
49. Lalla E et al. (2006). Periodontal changes in children and adolescents with diabetes: a case-control study. Diabetes Care 29, 295-9.
50. Langefeld CD et al. (2004). Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. American Journal of Kidney Disease 43, 796-800.
51. Lee ET et al. (2001). Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia 44(Suppl. 2), S3-13.
52. Levey AS et al. (2006). Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annals of Internal Medicine 145, 247-54.
53. Li S et al. (2007). Low birth weight is associated with chronic kidney disease only in men. Kidney International 73, 637-42.
54. Maahs DM et al. (2007). Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes. Diabetes Care 30, 2593-8.
55. Mattix HJ et al. (2002). Use of the albumin/creatinine ratio to detect microalbuminuria:implications of sex and race. Journal of the American Society of Nephrology 13, 1034-9.
56. Mauer SM et al. (1989). Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes 38, 516-23.
57. Meiland R et al. (2006). Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Archives of Internal Medicine 166, 2222-7.
58. Molitch ME et al. (2004). Nephropathy in diabetes. Diabetes Care 27(Suppl. 1), S79-83.
59. Morioka T et al. (2001). Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24, 909-13.
60. Muntner P et al. (2003). The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. Journal of the American Society of Nephrology 14, 1568-77.
61. Narayan KM et al. (2006). Impact of recent increase in incidence on future diabetes burden. Diabetes Care 29, 2114-16.
62. National Kidney Foundation (2002). K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. American Journal of Kidney Disease 39(Suppl. 1), S1-266.
63. National Kidney Foundation (2007). K/DOQI Clinical Practice Guidelines and Clinical Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Disease 49(Suppl. 2), S12-154.
64. Nelson RG (2003). Intrauterine determinants of diabetic kidney disease in disadvantaged populations. Kidney International. Supplement 83, 13-6.
65. Nelson RG et al. (1993). Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 36, 998-1001.
66. Nelson RG et al. (1995). Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 18, 182-7.
67. Nelson RG et al. (2008). Changing course of diabetic nephropathy in the Pima Indians. Diabetes Research and Clinical Practice 82(Suppl. 1), S10-4.
68. Nosadini R et al. (2000). Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49, 476-84.
69. ONTARGET Investigators (2008). Telmisartan, Ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine 358, 1547-59.
70. Orth SR et al. (2005). Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrology, Dialysis, Transplantation 20, 2414-9.
71. Otiniano ME et al. (2003). Self-reported diabetic complications and 7-year mortality in Mexican American elders. Findings from a community-based study of five Southwestern states. Journal of Diabetes Complications 17, 243-8.
72. Parving HH et al. (2006). Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney International 69, 2057-63.
73. Parving HH, Mauer M, Ritz E (2007). Diabetic nephropathy. In: Brenner BM, ed. Brenner & Rector's the Kidney, 8th ed., pp 1265-99. Philadelphia: Saunders Elsevier.
74. Pavkov ME et al. (2004). An explanation for the increase in heart disease mortality rates in diabetic Pima Indians: effect of renal replacement therapy. Diabetes Care 27, 1132-6.
75. Perkins BA et al. (2003). Regression of microalbuminuria in type 1 diabetes. New England Journal of Medicine 348, 2285-93.
76. Pinhas-Hamiel O, Zeitler P (2007). Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 369, 1823-31.
77. Retnakaran R et al. (2006). Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55, 1832-9.
78. Rigalleau V et al. (2007). Normoalbuminuric renal-insufficient diabetic patients: a lowerrisk group. Diabetes Care 30, 2034-9.
79. Rossing K et al. (2002). Pregnancy and progression of diabetic nephropathy. Diabetologia 45, 36-41.
80. Rossing P et al. (2002). Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25, 859-64.
81. Saaddine JB et al. (2006). Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Annals of Internal Medicine 144, 465-74.
82. Schelling JR et al. (2008). Genome-wide scan for estimated GFR in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes. Diabetes 57, 235-43.
83. Schoolwerth AC et al. (2006). Chronic kidney disease: a public health problem that needs a public health action plan. Preventing Chronic Disease 3(2), A57. Available at:. Accessed February 8, 2008.
84. Scott LJ et al. (2001). A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50, 2842-9.
85. Shoham DA et al. (2008). Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Social Science & Medicine 67, 1311-20.
86. Shultis WA et al. (2007). Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30, 306-11.
87. Staessen JA et al. (1997). The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. Journal of Hypertension 15, 1579-92.
88. Stevens LA et al. (2007). Evaluation of the Modification of Diet in Renal Disease Study Equation in a large, diverse population. Journal of the American Society of Nephrology 18, 2749-57.
89. Suh DC et al. (2008). Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. Journal of the American Geriatrics Society 56, 484-92.
90. Taylor GW, Borgnakke WS (2008). Periodontal disease: associations with diabetes, glycemic control and complications. Oral Diseases 14, 191-203.
91. Tershakovec AM et al. (2008). Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL Study. Diabetes Care 31, 445-7.
92. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-53.
93. U.S. Renal Data System (2007). USRDS 2007 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
94. U.S. Renal Data System (2008). USRDS 2008 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
95. Villar E et al. (2007). Effect of age, gender, and diabetes on excess death in end-stage renal failure. Journal of the American Society of Nephrology 18, 2125-34.
96. Wang Y et al. (2008). Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney International 73, 19-33.
97. Wasen E et al. (2004). Renal impairment associated with diabetes in the elderly. Diabetes Care 27, 2648-53.
98. Wolf G et al. (2002). Leptin and renal disease. American Journal of Kidney Disease 39, 1-11.
99. Wright JD et al. (2003). Dietary intake of ten key nutrients for public health, United States:1999-2000. Advance Data 334, 1-4.
100. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003). Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290, 2159-67.
101. Xu J et al. (2007). Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. American Journal of Kidney Disease 49, 208-16.
102. Yu CC et al. (1997). Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis. Peritoneal Dialysis International 17, 262-8.
103. Zimmet P, Alberti KG, Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature 414, 782-7.